share_log

Enliven Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(3.7%),Citadel Advisors Holdings LP(3.7%), etc.

Enliven Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Citadel Advisors LLC(3.7%),Citadel Advisors Holdings LP(3.7%)等

美股SEC公告 ·  11/15 05:29
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息